2014-07-16 |
1 |
|
trademark Atripla®.
16. United States.Patent No. 6,642,245 (“the ’245 Patent,” copy attached as
Exhibit A), …Infringement of U.S. Patent No. 6,642,245
23. Plaintiffs repeat and reallege paragraphs 1-22 above as …Action
l. This is an action for patent infringement under the patent laws of the
United States, Title…the United States Patent and Trademark
Office on Nover-nber 4, 2003. The ’245 Patent claims, inter alia…for Atripla®.
17. United States Patent No. 6,703,396 (“the ’396 Patent,” copy attached as
Exhibit B), |
External link to document |
2014-08-22 |
13 |
|
States Patent and Trademark Office (“PTO”), the PTO
issued United States Patent No. 6,642,245 B1 (“the…Trademark Office
issued U.S. Patent No. 6,642,245 B1 (“the ‘245 patent”), entitled “ANTIVIRAL ACTIVITY…
U.S. Patent No. 6,642,245
23. Lupin restates and incorporates… the PTO issued United States Patent No. 6,703,396 B1 (“the
‘396 patent”), titled “METHOD OF RESOLUTION… Patents-in-Suit
8. On or about November 4, 2003, the United States Patent and Trademark |
External link to document |
2014-08-05 |
8 |
|
2014.
The patents-in-suit in the newly-filed case (U.S. Patent Nos. 6,703,396, and 6,642,245) are also…6,703,396 and
claims 1, 2, 4 and 6 of U.S. Patent No. 6,642,245. Further, Lupin intends to stipulate to
… same patent claims in
this action as in No. 12-cv-6293_claims 1-7, 13, 15 and 16 ofU.S. Patent No. 6,… 17 September 2014
1:14-cv-05352
830 Patent
Defendant
District Court, S.D |
External link to document |